Showing 1 posts of 1 posts found.
The US Food and Drug Administration (FDA) has approved Probuphine, which is the first buprenorphine implant for the maintenance treatment …
NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases
EMA selects TrialAssure anonymisation platform for clinical trial documents
Researchers develop new antifungal compounds with improved safety profile
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor